Update of treatment for Gaucher disease

W Kong, C Lu, Y Ding, Y Meng - European Journal of Pharmacology, 2022 - Elsevier
Gaucher disease (GD), the most common lysosomal disorders, is a rare autosomal
recessive hereditary disease that is caused by deficiency of glucosylceramidase. For now …

Different Niemann-Pick C1 genotypes generate protein phenotypes that vary in their intracellular processing, trafficking and localization

H Shammas, EM Kuech, S Rizk, AM Das, HY Naim - Scientific reports, 2019 - nature.com
Abstract Niemann-Pick Type C (NP-C) is an inherited neurovisceral lysosomal storage
disease characterized by a defect in the trafficking of endocytosed cholesterol. In 95% of …

Gaucher Disease in Internal Medicine and Dentistry

M Basilicata, G Marrone, M Di Lauro, E Sargentini… - Applied Sciences, 2023 - mdpi.com
Gaucher disease (GD) is a lysosomal storage pathological condition, characterized by a
genetic autosomal recessive transmission. The GD cause is the mutation of GBA1 gene …

Structure-function analysis of human sucrase-isomaltase identifies key residues required for catalytic activity

B Gericke, N Schecker, M Amiri, HY Naim - Journal of Biological Chemistry, 2017 - ASBMB
Sucrase-isomaltase (SI) is an intestinal membrane-associated α-glucosidase that breaks
down di-and oligosaccharides to absorbable monosaccharides. SI has two homologous …

[HTML][HTML] Molecular pathogenicity of novel sucrase-isomaltase mutations found in congenital sucrase-isomaltase deficiency patients

B Gericke, M Amiri, CR Scott, HY Naim - Biochimica Et Biophysica Acta …, 2017 - Elsevier
Background & aims Congenital sucrase-isomaltase deficiency (CSID) is a genetic disorder
associated with mutations in the sucrase-isomaltase (SI) gene. The diagnosis of congenital …

ATP-binding cassette transporters mediate differential biosynthesis of glycosphingolipid species

M Budani, C Auray-Blais, C Lingwood - Journal of Lipid Research, 2021 - ASBMB
The cytosolic-oriented glucosylceramide (GlcCer) synthase is enigmatic, requiring nascent
GlcCer translocation to the luminal Golgi membrane to access glycosphingolipid (GSL) …

Glycosylation Modulation Dictates Trafficking and Interaction of SARS-CoV-2 S1 Subunit and ACE2 in Intestinal Epithelial Caco-2 Cells

M El Khoury, D Wanes, M Lynch-Miller, A Hoter… - Biomolecules, 2024 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mainly targets the upper
respiratory tract. It gains entry by interacting with the host cell receptor angiotensin …

Case study on the pathophysiology of Fabry disease: abnormalities of cellular membranes can be reversed by substrate reduction in vitro

G Brogden, H Shammas, K Maalouf, SL Naim… - Bioscience …, 2017 - portlandpress.com
It is still not entirely clear how α-galactosidase A (GAA) deficiency translates into clinical
symptoms of Fabry disease (FD). The present communication investigates the effects of the …

Efficacy and safety of miglustat in the treatment of GM2 gangliosidosis: A systematic review

V Mansouri, AR Tavasoli, M Khodarahmi… - European Journal of …, 2023 - Wiley Online Library
Background Since the results of previous studies regarding the safety and efficacy of
miglustat in GM2 gangliosidosis (GM2g) were inconsistent, we aimed to assess miglustat …

A double-blind, randomized, placebo-controlled trial studying the effects of Saccharomyces boulardii on the gastrointestinal tolerability, safety, and pharmacokinetics …

T Remenova, O Morand, D Amato… - Orphanet Journal of …, 2015 - Springer
Background Gastrointestinal (GI) disturbances such as diarrhea and flatulence are the most
frequent adverse effects associated with miglustat therapy in type 1 Gaucher disease (GD1) …